메뉴 건너뛰기




Volumn 118, Issue 10, 2011, Pages 2028-2034

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; RANIBIZUMAB;

EID: 80053608306     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.02.034     Document Type: Article
Times cited : (196)

References (35)
  • 1
    • 77952889477 scopus 로고    scopus 로고
    • Ranibizumab for macular edema following central retinal vein occlusion: Six-month primary end point results of a phase III study
    • CRUISE Investigators
    • D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
    • (2010) Ophthalmology , vol.117 , pp. 1124-1133
    • Brown, D.M.1    Campochiaro, P.A.2    Singh, R.P.3
  • 2
    • 77952891051 scopus 로고    scopus 로고
    • Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study
    • BRAVO Investigators
    • P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
    • (2010) Ophthalmology , vol.117 , pp. 1102-1112
    • Campochiaro, P.A.1    Heier, J.S.2    Feiner, L.3
  • 4
    • 77952779304 scopus 로고    scopus 로고
    • Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
    • Diabetic Retinopathy Clinical Research Network
    • M.J. Elman, L.P. Aiello, R.W. Beck Diabetic Retinopathy Clinical Research Network Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
    • (2010) Ophthalmology , vol.117 , pp. 1064-1077
    • Elman, M.J.1    Aiello, L.P.2    Beck, R.W.3
  • 5
    • 64449084175 scopus 로고    scopus 로고
    • Apoptotic mechanisms within the retina in Staphylococcus epidermidis experimental endophthalmitis
    • N.M. Pharmakakis, I.K. Petropoulos, and C.D. Georgakopoulos Apoptotic mechanisms within the retina in Staphylococcus epidermidis experimental endophthalmitis Graefes Arch Clin Exp Ophthalmol 247 2009 667 674
    • (2009) Graefes Arch Clin Exp Ophthalmol , vol.247 , pp. 667-674
    • Pharmakakis, N.M.1    Petropoulos, I.K.2    Georgakopoulos, C.D.3
  • 6
    • 66049110107 scopus 로고    scopus 로고
    • Endophthalmitis after anti-VEGF injections [letter]
    • K.S. Klein, M.K. Walsh, and T.S. Hassan Endophthalmitis after anti-VEGF injections [letter] Ophthalmology 116 2009 1225
    • (2009) Ophthalmology , vol.116 , pp. 1225
    • Klein, K.S.1    Walsh, M.K.2    Hassan, T.S.3
  • 7
    • 66349109710 scopus 로고    scopus 로고
    • Infectious endophthalmitis after intravitreal injection of antiangiogenic agents
    • T. Diago, C.A. McCannel, and S.J. Bakri Infectious endophthalmitis after intravitreal injection of antiangiogenic agents Retina 29 2009 601 605
    • (2009) Retina , vol.29 , pp. 601-605
    • Diago, T.1    McCannel, C.A.2    Bakri, S.J.3
  • 8
    • 43049101583 scopus 로고    scopus 로고
    • Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting
    • S. Pilli, A. Kotsolis, and R.F. Spaide Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting Am J Ophthalmol 145 2008 879 882
    • (2008) Am J Ophthalmol , vol.145 , pp. 879-882
    • Pilli, S.1    Kotsolis, A.2    Spaide, R.F.3
  • 9
    • 76749090090 scopus 로고    scopus 로고
    • Toxic vitritis outbreak after intravitreal injection
    • T. Ness, N. Feltgen, and H. Agostini Toxic vitritis outbreak after intravitreal injection Retina 30 2010 332 338
    • (2010) Retina , vol.30 , pp. 332-338
    • Ness, T.1    Feltgen, N.2    Agostini, H.3
  • 10
    • 64849085452 scopus 로고    scopus 로고
    • Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
    • M. Georgopoulos, K. Polak, and F. Prager Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin) Br J Ophthalmol 93 2009 457 462
    • (2009) Br J Ophthalmol , vol.93 , pp. 457-462
    • Georgopoulos, M.1    Polak, K.2    Prager, F.3
  • 12
    • 57949094834 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR Study
    • ANCHOR Study Group
    • D.M. Brown, M. Michels, P.K. Kaiser ANCHOR Study Group Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 2009 57 65
    • (2009) Ophthalmology , vol.116 , pp. 57-65
    • Brown, D.M.1    Michels, M.2    Kaiser, P.K.3
  • 14
    • 58949083350 scopus 로고    scopus 로고
    • Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab
    • D.R. Fintak, G.K. Shah, and K.J. Blinder Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab Retina 28 2008 1395 1399
    • (2008) Retina , vol.28 , pp. 1395-1399
    • Fintak, D.R.1    Shah, G.K.2    Blinder, K.J.3
  • 15
    • 75149116508 scopus 로고    scopus 로고
    • Intravitreal bevacizumab and ranibizumab for age-related macular degeneration: A multicenter, retrospective study
    • D.S. Fong, P. Custis, J. Howes, and J.W. Hsu Intravitreal bevacizumab and ranibizumab for age-related macular degeneration: a multicenter, retrospective study Ophthalmology 117 2010 298 302
    • (2010) Ophthalmology , vol.117 , pp. 298-302
    • Fong, D.S.1    Custis, P.2    Howes, J.3    Hsu, J.W.4
  • 16
    • 77949369713 scopus 로고    scopus 로고
    • Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch
    • K. Yamashiro, A. Tsujikawa, and K. Miyamoto Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch Retina 30 2010 485 490
    • (2010) Retina , vol.30 , pp. 485-490
    • Yamashiro, K.1    Tsujikawa, A.2    Miyamoto, K.3
  • 17
    • 54949136462 scopus 로고    scopus 로고
    • Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration
    • S.S. Wickremasinghe, K. Michalova, and J. Gilhotra Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration Ophthalmology 115 2008 1911 1915
    • (2008) Ophthalmology , vol.115 , pp. 1911-1915
    • Wickremasinghe, S.S.1    Michalova, K.2    Gilhotra, J.3
  • 18
    • 77954697544 scopus 로고    scopus 로고
    • Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor
    • D. Mezad-Koursh, M. Goldstein, and G. Heilwail Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor Retina 30 2010 1051 1057
    • (2010) Retina , vol.30 , pp. 1051-1057
    • Mezad-Koursh, D.1    Goldstein, M.2    Heilwail, G.3
  • 20
    • 0026344747 scopus 로고
    • Prophylaxis of endophthalmitis with topical povidone-iodine
    • M.G. Speaker, and J.A. Menikoff Prophylaxis of endophthalmitis with topical povidone-iodine Ophthalmology 98 1991 1769 1775
    • (1991) Ophthalmology , vol.98 , pp. 1769-1775
    • Speaker, M.G.1    Menikoff, J.A.2
  • 21
    • 67949109540 scopus 로고    scopus 로고
    • A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections
    • J.M. Moss, S.R. Sanislo, and C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 2009 1498 1501
    • (2009) Ophthalmology , vol.116 , pp. 1498-1501
    • Moss, J.M.1    Sanislo, S.R.2    Ta, C.N.3
  • 22
    • 52049105631 scopus 로고    scopus 로고
    • Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival
    • J.H. Boden, M.L. Myers, and T. Lee Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival J Cataract Refract Surg 34 2008 1773 1775
    • (2008) J Cataract Refract Surg , vol.34 , pp. 1773-1775
    • Boden, J.H.1    Myers, M.L.2    Lee, T.3
  • 23
    • 77951545882 scopus 로고    scopus 로고
    • Preoperative lidocaine gel [letter]
    • author reply 1049
    • S. Awotesu, and T. Eke Preoperative lidocaine gel [letter] Ophthalmology 117 2010 1049 author reply 1049
    • (2010) Ophthalmology , vol.117 , pp. 1049
    • Awotesu, S.1    Eke, T.2
  • 24
    • 33646948521 scopus 로고    scopus 로고
    • Pegaptanib sodium for neovascular age-related macular degeneration: Two-year safety results of the two prospective, multicenter, controlled clinical trials
    • VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group
    • VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials Ophthalmology 113 2006 992 1001
    • (2006) Ophthalmology , vol.113 , pp. 992-1001
  • 25
    • 6344251620 scopus 로고    scopus 로고
    • Minimizing the risk of endophthalmitis following intravitreous injections
    • DOI 10.1097/00006982-200410000-00003
    • C.N. Ta Minimizing the risk of endophthalmitis following intravitreous injections Retina 24 2004 699 705 (Pubitemid 39391759)
    • (2004) Retina , vol.24 , Issue.5 , pp. 699-705
    • Ta, C.N.1
  • 26
    • 33846244134 scopus 로고    scopus 로고
    • Reducing the risk of endophthalmitis following intravitreal injections
    • DOI 10.1097/IAE.0b013e3180307271, PII 0000698220070100000003
    • I.U. Scott, and H.W. Flynn Jr Reducing the risk of endophthalmitis following intravitreal injections Retina 27 2007 10 12 (Pubitemid 46095824)
    • (2007) Retina , vol.27 , Issue.1 , pp. 10-12
    • Scott, I.U.1    Flynn Jr., H.W.2
  • 27
    • 73349107165 scopus 로고    scopus 로고
    • Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: The Diabetic Retinopathy Clinical Research Network laser-ranibizumab-triamcinolone clinical trials
    • Diabetic Retinopathy Clinical Research Network
    • A.R. Bhavsar, J.M. Googe Jr, C.R. Stockdale Diabetic Retinopathy Clinical Research Network Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 2009 1581 1583
    • (2009) Arch Ophthalmol , vol.127 , pp. 1581-1583
    • Bhavsar, A.R.1    Googe, Jr.J.M.2    Stockdale, C.R.3
  • 28
    • 6344263392 scopus 로고    scopus 로고
    • Evolving guidelines for intravitreous injections
    • L.P. Aiello, A.J. Brucker, and S. Chang Evolving guidelines for intravitreous injections Retina 24 suppl 2004 S3 S19
    • (2004) Retina , vol.24 , Issue.SUPPL.
    • Aiello, L.P.1    Brucker, A.J.2    Chang, S.3
  • 30
    • 0037564127 scopus 로고    scopus 로고
    • Glaucoma-filtering bleb infections
    • DOI 10.1097/00055735-200304000-00007
    • I. Mac, and J.B. Soltau Glaucoma-filtering bleb infections Curr Opin Ophthalmol 14 2003 91 94 (Pubitemid 36584228)
    • (2003) Current Opinion in Ophthalmology , vol.14 , Issue.2 , pp. 91-94
    • Mac, I.1    Soltau, J.B.2
  • 31
    • 0001099413 scopus 로고
    • Value of cultures before operation for cataract
    • J.H. Dunnington, and D. Locatcher-Khorazo Value of cultures before operation for cataract Arch Ophthal 34 1945 215 219
    • (1945) Arch Ophthal , vol.34 , pp. 215-219
    • Dunnington, J.H.1    Locatcher-Khorazo, D.2
  • 32
    • 26844543549 scopus 로고    scopus 로고
    • Re: Evolving guidelines for intravitreous injections [letter]
    • author reply 950
    • S.J. Garg, and F.M. Recchia Re: Evolving guidelines for intravitreous injections [letter] Retina 25 2005 949 950 author reply 950
    • (2005) Retina , vol.25 , pp. 949-950
    • Garg, S.J.1    Recchia, F.M.2
  • 33
    • 0028839594 scopus 로고
    • Results of the Endophthalmitis Vitrectomy Study: A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis
    • Endophthalmitis Vitrectomy Study Group
    • Endophthalmitis Vitrectomy Study Group Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis Arch Ophthalmol 113 1995 1479 1496
    • (1995) Arch Ophthalmol , vol.113 , pp. 1479-1496
  • 34
    • 0030885287 scopus 로고    scopus 로고
    • Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study
    • M. Barza, P.R. Pavan, B.H. Doft Endophthalmitis Vitrectomy Study Group Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study Arch Ophthalmol 115 1997 1142 1150 (Pubitemid 27387950)
    • (1997) Archives of Ophthalmology , vol.115 , Issue.9 , pp. 1142-1150
    • Barza, M.1    Pavan, P.R.2    Doft, B.H.3    Wisniewsfci, S.R.4    Wilson, L.A.5    Han, D.P.6    Kehey, S.F.7
  • 35
    • 42049115622 scopus 로고    scopus 로고
    • Intraocular inflammation following intravitreal injection of bevacizumab
    • S.J. Bakri, T.A. Larson, and A.O. Edwards Intraocular inflammation following intravitreal injection of bevacizumab Graefes Arch Clin Exp Ophthalmol 246 2008 779 781
    • (2008) Graefes Arch Clin Exp Ophthalmol , vol.246 , pp. 779-781
    • Bakri, S.J.1    Larson, T.A.2    Edwards, A.O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.